COVID-19 Infection in Patients Receiving Anti-CD20 Therapy
NCT04884477
·
clinicaltrials.gov ↗
COMPLETED
Status
342
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Immunosuppressed Host
Convalescent Plasma
Anti-CD20 Therapy
Interventions
BIOLOGICAL:
Convalescent Plasma
Sponsor
Mayo Clinic